Literature DB >> 19802732

Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier.

Katsuya Fujimoto1, Tomoyuki Endo2, Mitsufumi Nishio1, Masato Obara1, Keisuke Yamaguchi1, Yukari Takeda1, Hideki Goto1, Ikumi Kasahara1, Norihiro Sato3, Takao Koike1.   

Abstract

A 44-year-old female presented with asymptomatic leukocytosis and moderate splenomegaly. The diagnosis of splenic marginal zone lymphoma (SMZL) was made by a splenectomy. A virological examination revealed the patient to be a hepatitis B virus (HBV) carrier. The lymphocyte count in her peripheral blood decreased after splenectomy, but remained high for 2 years and bone marrow infiltration was obvious. Two years after the splenectomy, she was admitted for an acute flare-up of hepatitis B. The liver dysfunction improved without any medication and thereafter returned to the normal range within a few weeks. At the same time, the lymphocyte count in her peripheral blood rapidly decreased to normal levels. Atypical lymphocytes disappeared from the peripheral blood and bone marrow aspirates and biopsy specimen revealed complete remission of SMZL, including the disappearance of the clonal rearrangement of IgH-JH. There has been no recurrence of acute hepatitis and she has been in complete remission for SMZL for more than 6 years. The clinical course of this patient suggests that an immune response against HBV also affects the clearance of lymphoma cells. This is the first report that a complete remission was achieved in a patient with SMZL after a hepatitis B flare-up.

Entities:  

Mesh:

Year:  2009        PMID: 19802732     DOI: 10.1007/s12185-009-0426-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  17 in total

1.  Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hématologie Cellulaire (GFHC).

Authors:  X Troussard; F Valensi; E Duchayne; R Garand; P Felman; M Tulliez; M Henry-Amar; P A Bryon; G Flandrin
Journal:  Br J Haematol       Date:  1996-06       Impact factor: 6.998

2.  Splenic marginal zone cell lymphoma.

Authors:  C Schmid; N Kirkham; T Diss; P G Isaacson
Journal:  Am J Surg Pathol       Date:  1992-05       Impact factor: 6.394

3.  Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B.

Authors:  S Rossol; G Marinos; P Carucci; M V Singer; R Williams; N V Naoumov
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

4.  High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.

Authors:  Feng Wang; Rui-Hua Xu; Bing Han; Yan-Xia Shi; Hui-Yan Luo; Wen-Qi Jiang; Tong-Yu Lin; Hui-Qiang Huang; Zhong-Jun Xia; Zhong-Zhen Guan
Journal:  Cancer       Date:  2007-04-01       Impact factor: 6.860

Review 5.  Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

Authors:  Catherine Thieblemont; Pascale Felman; Francoise Berger; Charles Dumontet; Philippe Arnaud; Olivier Hequet; Josette Arcache; Evelyne Callet-Bauchu; Gilles Salles; Bertrand Coiffier
Journal:  Clin Lymphoma       Date:  2002-06

6.  Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies.

Authors:  Keitaro Matsuo; Aaron Kusano; Aravind Sugumar; Shigeo Nakamura; Kazuo Tajima; Nancy E Mueller
Journal:  Cancer Sci       Date:  2004-09       Impact factor: 6.716

7.  Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.

Authors:  Lajos Gergely; Magdolna Aleksza; László Váróczy; Andrea Ponyi; Sándor Sipka; Arpád Illés; Gyula Szegedi
Journal:  Eur J Haematol       Date:  2004-05       Impact factor: 2.997

8.  Splenic marginal zone lymphoma: a prognostic model for clinical use.

Authors:  Luca Arcaini; Mario Lazzarino; Nora Colombo; Sara Burcheri; Emanuela Boveri; Marco Paulli; Enrica Morra; Marcello Gambacorta; Sergio Cortelazzo; Alessandra Tucci; Marco Ungari; Achille Ambrosetti; Fabio Menestrina; Lorella Orsucci; Domenico Novero; Alessandro Pulsoni; Maurizio Frezzato; Gianluca Gaidano; Daniele Vallisa; Viviana Minardi; Claudio Tripodo; Vincenzo Callea; Luca Baldini; Francesco Merli; Massimo Federico; Vito Franco; Emilio Iannitto
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

9.  Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.

Authors:  M Mollejo; J Menárguez; E Lloret; A Sánchez; E Campo; P Algara; E Cristóbal; E Sánchez; M A Piris
Journal:  Am J Surg Pathol       Date:  1995-10       Impact factor: 6.394

10.  Inhibition of B lymphocyte activation by interferon-gamma.

Authors:  D S Reynolds; W H Boom; A K Abbas
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

View more
  6 in total

1.  Splenic marginal zone lymphoma masquerading as cirrhotic hypersplenism for seven years.

Authors:  John Alfred Carr
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

2.  Spontaneous remission in localized diffuse large B-cell lymphoma.

Authors:  László Tamás; Eszter Sári; Gábor Répássy; Péter Szabó; Eniko Bagdi; László Krenács; Judit Demeter
Journal:  Pathol Oncol Res       Date:  2011-06-10       Impact factor: 3.201

3.  Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.

Authors:  Eric A Engels; Eo Rin Cho; Sun Ha Jee
Journal:  Lancet Oncol       Date:  2010-08-03       Impact factor: 41.316

4.  Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region.

Authors:  Shuhua Yi; Yuting Yan; Wenjie Xiong; Rui Lv; Zhen Yu; Wei Liu; Enbin Liu; Heng Li; Huimin Liu; Zengjun Li; Gang An; Yan Xu; Kun Ru; Dehui Zou; Lugui Qiu
Journal:  Oncotarget       Date:  2017-10-19

5.  Prevalence of hepatitis B and hepatitis C viral infections in various subtypes of B-cell non-Hodgkin lymphoma: confirmation of the association with splenic marginal zone lymphoma.

Authors:  W Xiong; R Lv; H Li; Z Li; H Wang; W Liu; D Zou; L Qiu; S Yi
Journal:  Blood Cancer J       Date:  2017-03-31       Impact factor: 11.037

6.  The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer.

Authors:  Xiao-li Wei; Miao-zhen Qiu; Wei-wei Chen; Ying Jin; Chao Ren; Feng Wang; Hui-yan Luo; Zhi-qiang Wang; Dong-sheng Zhang; Feng-hua Wang; Yu-hong Li; Rui-hua Xu
Journal:  J Transl Med       Date:  2013-10-08       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.